📊 XNCR Key Takeaways
Is Xencor Inc (XNCR) a Good Investment?
Xencor faces acute financial distress with only $14.2M in cash reserves while burning $68.2M annually in free cash flow, representing less than 2.5 months of operational runway. The company's $4.5M in revenue cannot support its $77.9M operating expense base, with net losses of $128.9M indicating fundamental economic dysfunction. Immediate financing need or drastic restructuring is required to ensure survival.
Xencor Inc Key Strengths (XNCR)
- Low leverage with debt-to-equity ratio of 0.16x indicates manageable debt burden
- Reasonable asset base of $736.8M provides collateral for potential financing
- Revenue growth of 13.7% YoY demonstrates some market acceptance and commercial traction
XNCR Stock Risks: Xencor Inc Investment Risks
- Critical liquidity crisis: $14.2M cash with $68.2M annual burn rate equals approximately 2.5 months of runway
- Operating losses of $77.9M vastly exceed revenues of $4.5M, indicating unsustainable business model
- Net losses of $128.9M annually with operating margins of -1724% show no visible path to profitability
Key Metrics to Watch
- Monthly cash burn rate and cash position - critical monitoring for solvency
- Revenue growth rate relative to operating expense growth trajectory
- Debt covenant compliance status and refinancing availability
Xencor Inc (XNCR) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 6.57x current ratio provides a solid financial cushion.
XNCR Profit Margin, ROE & Profitability Analysis
XNCR vs Healthcare Sector: How Xencor Inc Compares
How Xencor Inc compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Xencor Inc Stock Overvalued? XNCR Valuation Analysis 2026
Based on fundamental analysis, Xencor Inc has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Xencor Inc Balance Sheet: XNCR Debt, Cash & Liquidity
XNCR Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Xencor Inc's revenue has declined by 37% over the 5-year period, indicating business contraction. The most recent EPS of $-2.20 indicates the company is currently unprofitable.
XNCR Revenue Growth, EPS Growth & YoY Performance
XNCR Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $4.5M | -$48.4M | $-0.66 |
| Q3 2025 | $17.8M | -$6.0M | $-0.08 |
| Q2 2025 | $23.9M | -$30.8M | $-0.41 |
| Q1 2025 | $16.0M | -$48.4M | $-0.66 |
| Q3 2024 | $10.7M | -$24.3M | $-0.40 |
| Q2 2024 | $17.0M | -$22.0M | $-0.37 |
| Q1 2024 | $12.8M | -$60.8M | $-1.02 |
| Q3 2023 | $27.3M | -$24.3M | $-0.40 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Xencor Inc Dividends, Buybacks & Capital Allocation
XNCR SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Xencor Inc (CIK: 0001326732)
📋 Recent SEC Filings
❓ Frequently Asked Questions about XNCR
What is the AI rating for XNCR?
Xencor Inc (XNCR) has an AI grade of D with 85% confidence, based on fundamental analysis of SEC EDGAR filings.
What are XNCR's key strengths?
Claude: Low leverage with debt-to-equity ratio of 0.16x indicates manageable debt burden. Reasonable asset base of $736.8M provides collateral for potential financing.
What are the risks of investing in XNCR?
Claude: Critical liquidity crisis: $14.2M cash with $68.2M annual burn rate equals approximately 2.5 months of runway. Operating losses of $77.9M vastly exceed revenues of $4.5M, indicating unsustainable business model.
What is XNCR's revenue and growth?
Xencor Inc reported revenue of $4.5M.
Does XNCR pay dividends?
Xencor Inc does not currently pay dividends.
Where can I find XNCR SEC filings?
Official SEC filings for Xencor Inc (CIK: 0001326732) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is XNCR's EPS?
Xencor Inc has a diluted EPS of $-1.71.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is XNCR's fundamental grade?
Based on our AI fundamental analysis in June 2026, Xencor Inc has a D grade with 85% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is XNCR stock overvalued or undervalued?
Valuation metrics for XNCR: ROE of -25.0% (sector avg: 15%), net margin of -2,854.7% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is XNCR's AI grade for 2026?
Our dual AI analysis gives Xencor Inc a combined D grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is XNCR's free cash flow?
Xencor Inc's operating cash flow is $-67.6M, with capital expenditures of $610.0K. FCF margin is -1,511.0%.
How does XNCR compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -2,854.7% (avg: 12%), ROE -25.0% (avg: 15%), current ratio 6.57 (avg: 2).